NEW YORK (GenomeWeb) – Transgenomic today announced an agreement to sell the rights to it Surveyor Nuclease technology and assets to Integrated DNA Technologies for a minimum of $4.25 million.

IDT will make a $3.65 million upfront payment with additional payments totaling at least $600,000 in the first year of the agreement. Rights to the Surveyor patents, license, technology, know-how, and trademarks, and all product inventory will be transferred to IDT.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.